Reduced-Intensity Stem Cell Transplantation for Hematological Malignancies: Current Status and the Future

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 2, 2007-05 ,pp. : 149-162

Bentham Science Publishers

Access to resources Recommend Favorite

Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

By Nagler A.   Or R.   Naparstek E.   Varadi G.   Slavin S.  

Experimental Hematology, Vol. 28, Iss. 9, 2000-09 ,pp. : 1096-1104

Elsevier

Access to resources Recommend Favorite

Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review

By Baron Frédéric  

Springer Seminars in Immunopathology, Vol. 26, Iss. 1-2, 2004-11 ,pp. : 71-94

Springer Publishing Company

Access to resources Recommend Favorite

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 1, 2011-03 ,pp. : 16-28

Bentham Science Publishers

Access to resources Recommend Favorite

Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation

By Goede Jeroen   Misselwitz Benjamin   Taverna Christian   Schanz Urs   Dispenzieri Angela   Hummel Yvonne   Trüeb Ralph   Fehr Jörg  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 303-306

Springer Publishing Company

Access to resources Recommend Favorite